| 1L | 1 layer |
| 2D | two-dimensional |
| 2L | 2 layers |
| 3D | three-dimensional |
| 3L | 3 layers |
| AgNPs | Silver nanoparticles |
| AgSD | silver sulfadiazine |
| ALG | alginate |
| ATM | Advanced Therapy Medicines |
| CaALG | calcium alginate |
| CAD | computer Aided Design |
| CATMPs | Combined advanced therapy medicinal products |
| CHS | Chitosan |
| CHSG | chitosan glutamate |
| CL | Collagen |
| CS | chondroitin sulfate |
| c-SLN | coated Solid Lipid Nanoparticles |
| CVR | carvacrol |
| DHT | dehydrothermal treatment |
| DMEM | Dulbecco’s Modified Eagle’s Medium |
| DoE | Design of Experiment |
| ECM | extracellular matrix |
| EDC | Ethyl-3-(3-dimethylaminopropyl)carbodiimide)-based |
| EMA | European Medicine Agency |
| ETO: | Ethylene oxide |
| FDA | Food and Drug Administration |
| GAG | glycosaminoglycans |
| GFs | growth factors |
| GG | gellan |
| GLY | glycine |
| GNPs | graphene nanoplatelets |
| GP | glycerophosphate |
| HA | hyaluronic acid |
| HAL | halloysite |
| HC | homochiral crystallites |
| H-chain | heavy chain |
| HCHS | chitosan hydrochloride |
| HTNs | halloysite nanotubes |
| HYBD | clay hybrid |
| IBD | Inflammatory Bowel Disease |
| IL | interleukin |
| L-chain | light chain |
| M0 | naive macrophages |
| M1 | pro-inflammatory macrophages |
| M2 | anti-inflammatory macrophages |
| Mats | matrices |
| MBG | mesoporous bioactive glasses |
| MH | Manuka Honey |
| MMPS | metalloproteinases |
| mMSC | murine mesenchymal stem cells |
| MMT | montmorillonite |
| MPC | 5-methyl-pyrrolidinone chitosan |
| MSC | mesenchymal stem cells |
| MW | molecular weight |
| NCs | nanocomposites |
| NPs | nanoparticles |
| OCMCHS | O-carboxymethyl chitosan |
| PCL | poly(ε-caprolactone) |
| PDGF-AB | Platelet-Derived Growth Factor-AB |
| PDLA | poly(d-lactic acid) |
| PDLLA | poly(dl-lactic acid) |
| PEC | pectin |
| PEO | polyethylene oxide |
| PGA | polyglycolide |
| PHC | palygorskite |
| pI | protein isoelectric point |
| PL | platelet lysate |
| PLA | polylactide |
| PLA-PCL | Polylactide-co-polycaprolactone |
| PLGA | Polylactide-co-glycolide |
| PLLA | poly(l-lactic acid) |
| p-MSCs | bone marrow mesenchymal stem cells |
| PRP | platelet rich plasma |
| Pul | pullulan |
| PUR | polyurethane |
| PVA | poly(vinylalcohol) |
| PVP | poly (vinylpyrrolidone) |
| pxch | chemically effective crosslinking |
| pxel | elastically effective crosslinking |
| RC-33 | 1-[3-(1,10-biphen)-4-yl] butylpiperidine |
| RGD | Arg-Gly-Asp |
| ROP | ring-opening polymerization |
| RSF | regenerated silk fibroin |
| SC | stereocomplex crystallites |
| SD | substitution degree |
| SF | silk fibroin |
| SS | sericin |
| TA | tranexamic acid |
| TEP | tissue-engineered products or medicines |
| TMC | Trimethyl chitosan |
| TNF | Tumor Necrosis Factor |
| VCM | vancomycin hydrochloride |